Swiss National Bank Pmv Pharmaceuticals, Inc. Transaction History

Swiss National Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$4.77 - $9.16 $18,126 - $34,808	-3,800 Reduced 7.88%	44,400 $211,000
Q2 2022 Aug 09, 2022	BUY	$9.23 - $22.43 $197,522 - $480,002	21,400 Added 79.85%	48,200 $687,000
Q1 2022 May 09, 2022	BUY	$14.86 - $23.55 $31,206 - $49,455	2,100 Added 8.5%	26,800 $558,000
Q2 2021 Aug 06, 2021	BUY	$28.01 - $36.01 $691,847 - $889,447	24,700 New	24,700 $844,000

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.